EFFECTS OF HM15211, A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, ON ANTI-INFLAMMATION AND ANTI-FIBROSIS IN TAA-INDUCED MOUSE MODEL OF LIVER INJURY AND FIBROSIS

被引：0
|
作者：
Kwon, Hyunjoo [1 ]
Kim, Jung Kuk [1 ]
Lee, Jong Suk [1 ]
Kim, Yohan [1 ]
Park, Eun Jin [1 ]
Choi, Jaehyuk [2 ]
Bae, Sung Min [1 ]
Kim, Dae Jin [1 ]
Lee, Sang Hyun [1 ]
Choi, In Young [1 ]
机构：
[1] Hanmi Pharm Co Ltd, Seoul, South Korea
[2] 14 Wiryeseong Daero, Wiryeseong Daero, South Korea
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2453
引用
收藏
页码：S716 / S717
页数：2
相关论文
共 50 条
  • [1] ANTI -INFLAMMATION AND ANTI-FIBROSIS EFFECTS OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST TRIPLE AGONIST (HM15211) IN AMLN/TAA INDUCED MOUSE MODEL OF LIVER INFLAMMATION AND FIBROSIS
    Lee, Jong Suk
    Jo, Hyo Sang
    Kim, Jung Kuk
    Lee, Seon Myeong
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1010 - 1011
  • [2] HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist, Exhibits Anti-inflammatory and Fibrotic Effects in AMLN/TAA-Induced Liver Inflammation and Fibrosis Mice
    Kim, Jung Kuk
    Lee, Jong Suk
    Park, Eunjin
    Lee, Jongsoo
    Bae, Sungmin
    Kim, Daejin
    Choi, In Young
    DIABETES, 2020, 69
  • [3] Anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in TAA induced mouse model of liver injury and fibrosis
    Kim, J.
    Lee, J.
    Kim, Y.
    Lee, S.
    Kwon, H.
    Park, E.
    Choi, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S400 - S401
  • [4] ANTI -FIBROTIC EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST (HM15211) IN BDL-INDUCED MOUSE MODEL OF LIVER FIBROSIS
    Kim, Jung Kuk
    Jo, Hyo Sang
    Lee, Seon Myeong
    Lee, Jong Suk
    Kwon, Hyunjoo
    Lee, Jong Soo
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1009 - 1010
  • [5] Novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) exhibits anti-inflammatory and - fibrotic effects in AMLN/TAA induced liver inflammation and fibrosis mice
    Jo, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S417 - S417
  • [6] Anti-fibrotic potential of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in preclinical models of fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Lee, Seon Myeong
    Choi, Jae Hyuk
    Kwon, Hyunjoo
    Park, Enu Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2021, 75 : S614 - S614
  • [7] Anti-fibrotic potential of a novel long-acting glucagon/GIP/GLP-1 triple agonist (HM15211) in preclinical models of fibrosis
    Kim, J.
    Lee, J.
    Lee, S.
    Kwon, H.
    Park, E.
    Bae, S.
    Kim, D.
    Kim, Y.
    Choi, I.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 348 - 349
  • [8] Direct Anti-Inflammatory and Antifibrotic Effects of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist, HM15211, in Thioacetamide-Induced Mouse Model of Liver Injury and Fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Lee, Seon Myeong
    Kwon, Hyunjoo
    Park, Eunjin
    Choi, Jaehyuk
    Bae, Sungmin
    Kim, Daejin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2022, 71
  • [9] Direct anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in thioacetamide-induced mouse model of liver injury and fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Lee, Seonmyeong
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2022, 77 : S469 - S469
  • [10] Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a NASH and Fibrosis Animal Model
    Choi, In Young
    Kim, Jung Kuk
    Lee, Jong Suk
    Park, Eunjin
    Kim, Young Hoon
    Jung, Sung Youb
    Kim, Sun Jin
    DIABETES, 2018, 67
12345